Literature DB >> 7796250

Quantified multidimensional assessment of autism and other pervasive developmental disorders. Application for bioclinical research.

L Hameury1, S Roux, C Barthélémy, J L Adrien, H Desombre, D Sauvage, B Garreau, G Lelord.   

Abstract

A large number of investigation techniques are used to establish the relationships between the clinical and biological data which are necessary for physiopathological analysis in the field of developmental disorders. It therefore seemed necessary to develop a quantified grouping system, based on developmental assessments, which could allow closer matching between clinical evaluations and biological numerical data. Two hundred and two subjects presenting developmental disorders (autistic disorder, pervasive developmental disorder not otherwise specified and mental retardation) were examined. For each child, a quantification of autistic behaviour, intellectual impairment, neurological signs and language and communication disorders was performed. A cluster analysis of these quantified data elicited four subgroups according to the scores obtained in these four different areas. We showed the value of this approach by applying it to one of the studies of monoamines routinely examined in childhood autism--dopamine and HVA, its main urinary derivative. Moreover, this method revealed a subgroup within the total population which was independent of nosographic classification and which had a particular clinical and biochemical profile. Other applications could follow, for example in the fields of neurophysiology, cerebral imaging, molecular biology and genetics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796250     DOI: 10.1007/bf01977740

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  11 in total

1.  Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.

Authors:  D J Cohen; B A Shaywitz; W T Johnson; M Bowers
Journal:  Arch Gen Psychiatry       Date:  1974-12

2.  [Measurement of agreement between 2 judges. Qualitative cases].

Authors:  J Fermanian
Journal:  Rev Epidemiol Sante Publique       Date:  1984       Impact factor: 1.019

3.  Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior.

Authors:  D V Cicchetti; S A Sparrow
Journal:  Am J Ment Defic       Date:  1981-09

4.  Blind ratings of early symptoms of autism based upon family home movies.

Authors:  J L Adrien; P Lenoir; J Martineau; A Perrot; L Hameury; C Larmande; D Sauvage
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-05       Impact factor: 8.829

5.  Autism and pervasive developmental disorders: concepts and diagnostic issues.

Authors:  M Rutter; E Schopler
Journal:  J Autism Dev Disord       Date:  1987-06

6.  Urinary homovanillic acid levels of autistic children.

Authors:  B Garreau; C Barthélémy; J Jouve; N Bruneau; J P Muh; G Lelord
Journal:  Dev Med Child Neurol       Date:  1988-02       Impact factor: 5.449

7.  The Behavioral Summarized Evaluation: validity and reliability of a scale for the assessment of autistic behaviors.

Authors:  C Barthelemy; J L Adrien; P Tanguay; B Garreau; J Fermanian; S Roux; D Sauvage; G Lelord
Journal:  J Autism Dev Disord       Date:  1990-06

Review 8.  [Neurological aspects of infantile autism].

Authors:  G Lelord; B Garreau; C Barthelemy; N Bruneau; D Sauvage
Journal:  Encephale       Date:  1986 Mar-Apr       Impact factor: 1.291

9.  Childhood psychosis and monoamine metabolites in spinal fluid.

Authors:  C Gillberg; L Svennerholm; C Hamilton-Hellberg
Journal:  J Autism Dev Disord       Date:  1983-12

10.  Urinary free and conjugated catecholamines and metabolites in autistic children.

Authors:  C Barthelemy; N Bruneau; J M Cottet-Eymard; J Domenech-Jouve; B Garreau; G Lelord; J P Muh; L Peyrin
Journal:  J Autism Dev Disord       Date:  1988-12
View more
  5 in total

Review 1.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Validation of the Revised Behavior Summarized Evaluation Scale.

Authors:  C Barthélémy; S Roux; J L Adrien; L Hameury; P Guérin; B Garreau; J Fermanian; G Lelord
Journal:  J Autism Dev Disord       Date:  1997-04

3.  Subtypes of autism by cluster analysis based on structural MRI data.

Authors:  Michal Hrdlicka; Iva Dudova; Irena Beranova; Jiri Lisy; Tomas Belsan; Jiri Neuwirth; Vladimir Komarek; Ludvika Faladova; Marketa Havlovicova; Zdenek Sedlacek; Marek Blatny; Tomas Urbanek
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-05       Impact factor: 4.785

Review 4.  Medication treatment in subjects with autistic spectrum disorders.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

5.  Autism and developmental delay: a comparative clinical study in very young children using IBSE scale.

Authors:  Hugues Desombre; Joelle Malvy; Sylvie Roux; Régis de Villard; Dominique Sauvage; Jean Dalery; Pascal Lenoir
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-13       Impact factor: 4.785

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.